Qingdao Saber Technology Pharma QST
Finnrick has tested 13 samples from Qingdao Saber Technology Pharma QST across 2 products.
Take Action
Request Full Data Access to the Finnrick database of peptide tests.
Products
| Tests | ||||||||
|---|---|---|---|---|---|---|---|---|
| Product | Rating | Count | Avg | Min | Max | Oldest | Most Recent | |
| Retatrutide | 9 | 3 Jun 2025 | 1 Jun 2026 | |||||
| Tirzepatide | 4 | 2 Jul 2025 | 30 Dec 2025 | |||||
The Qingdao Saber Technology Pharma QST samples tested by Finnrick were either acquired by Finnrick directly, or submitted by the public.
Customer Reviews
These indicators of customer satisfaction are based on reports submitted by the public through the Finnrick testing program, and are not verified.
Based on 5 overall satisfaction reports
People who submitted test requests to Finnrick gave Qingdao Saber Technology Pharma QST an average satisfaction rating of 5.0 out of 5 across 5 reports associated with samples received and tested by Finnrick.
Most recent Qingdao Saber Technology Pharma QST tests
Samples are tested in commercial labs
tests
products
Scores
First
Last
| Quantity | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Product | Certificate | Test Score | Label | Tested | Difference | Purity | Batch ID | Container | Tested At | Sent By |
| 1 Jun 2026 | Retatrutide | View | 30mg | ⚠️ Sample does not contain Retatrutide | R3025Ja01 | No label / Silver crimp / Red cap | Lab G | Public | |||
| 23 Apr 2026 | Retatrutide | View | 5mg | 5.11mg | +2.2% | 99.90% | R525La01 | No Label / Silver Crimp / Blue Cap | Lab E | Public | |
| 30 Dec 2025 | Tirzepatide | View | 30mg | 34.1mg | +13.7% | 99.71% | T3025Ja01 | No Label / Silver Crimp / Black Cap | Lab E | Public | |
| 29 Dec 2025 | Retatrutide | View | 20mg | 22mg | +10.0% | 99.60% | R2025Ja01 | No Label / Silver Crimp / Violet Cap | Lab G | Public | |
| 11 Dec 2025 | Tirzepatide | View | 60mg | 63.9mg | +6.5% | 99.95% | T6025Ja01 | No Label / Silver Crimp / Orange Cap | Lab E | Public | |
| 11 Dec 2025 | Retatrutide | View | 10mg | 10.4mg | +4.0% | 99.92% | R1025Ja01 | No Label / Silver Crimp / Clear Blue Cap | Lab E | Public | |
| 1 Sep 2025 | Retatrutide | View | 5mg | 5.68mg | +13.6% | 99.45% | (no batch ID) | No Label / Silver Crimp / Clear Blue Cap | Lab F | Public | |
About Qingdao Saber Technology Pharma QST Test Results From Finnrick
Qingdao Saber Technology Pharma QST is a peptide vendor with multiple products tracked in the independent testing dataset collected by Finnrick. This page compiles recent, batch-level test results across 2 products and 13 tests, including scores, test dates, batch IDs, and lab details. This enables you to compare quality over time, not just marketing claims.
Each tested sample receives a 0–10 score, with 10 being the best possible value. It is the total of three components: purity (0–4 points), quantity accuracy vs. the label or batch claim (0–4 points), and batch information quality (0–2 points).
When several test results are available for a product and vendor pair, you’ll also find a Finnrick Rating (A–E, where A is best and E is worst, X if an insufficient number of tests is available, or F in rare cases of documented and widespread fraud) and customer satisfaction reports with sub-scores that provide additional context. Use the table above to review purity, quantity accuracy, consistency between batches, and any notable outliers surfaced in Finnrick testing data.
Qingdao Saber Technology Pharma QST Testing Activity & Score Summary
In the past 30 days, Finnrick has published 1 new test result for Qingdao Saber Technology Pharma QST, and 2 in the past three months. The overall dataset includes 13 tested samples with an average score of 6.3/10 across all products.
Across 13 identity-tested samples, 85% were confirmed to contain the expected peptide (identity pass rate). Among those that passed, median purity was 99.8%. Approximately 100% of passing samples tested at or above 98% purity.
Here is a closer look at the most frequently tested products (top 2):
- Retatrutide (9 tests, 89% identity pass, median purity 99.7%) — Test scores are highly variable, ranging from 2.0 to 10.0 (average 6.4/10), suggesting significant batch-to-batch differences.
- Tirzepatide (4 tests, 75% identity pass, median purity 99.8%) — Test scores are highly variable, ranging from 0.0 to 9.5 (average 6.2/10), suggesting significant batch-to-batch differences.